Huntington's disease and neuroacanthocytosis may present similar clinical and MRI features. It is important to differentiate these findings since treatment and prognosis vary vastly between them. The aim of this article is to familiarize radiologists with the differentiating features of Huntington's disease and various diseases comprising neuroacanthocytosis. A 40-year-old Indian man with extrapyramidal symptoms was referred for MRI. The clinical diagnosis was Huntington's disease, but there were a few atypical clinical features such as a history of biting the tongue, tics, marked hyporeflexia and lower limb muscle wasting. MR showed atrophy of the caudate nucleus and putamen with iron deposition in the basal ganglia, which can be seen in Huntington's disease and in neuroacanthocytosis. An increased blood acanthocyte level was subsequently confirmed. Further work-up revealed increased serum creatine phosphokinase levels, normal serum lipoprotein levels and depressed K cell antigen activity on serological studies, confirming the diagnosis of McLeod syndrome. McLeod syndrome is one of the distinct phenotypes of neuroacanthocytosis. Neuroacanthocytosis is a group of disorders with increased serum acanthocyte counts and neurological involvement. Various causes of neuroacanthocytosis are discussed. It is important to consider the possibility of neuroacanthocytosis when features typical of Huntington's disease are encountered on imaging.
Introduction
Neuroacanthocytosis is a progressive neurologic condition characterized by movement disorders, axonal neuropathy, personality changes, cognitive deterioration and seizures. Most patients have acanthocytosis on peripheral blood smear at some point during the course of the disease. Neuroacanthocytosis was first described by Levine in 1960 in a presentation to the American Academy of Neurology. Estes et al., Levine, and Critchley et al. published the first case descriptions 1, 2 . The term acanthocytosis is derived from the Greek word "acanthos" meaning "thorn" and is used to describe a peculiar spiky appearance of erythrocytes. Acanthocytosis is found to be associated with a group of hereditary neurological disorders generally referred to as neuroacanthocy-tosis such as chorea-acanthocytosis, McLeod syndrome, abetalipoproteinaemia, hypobetalipoproteinaemia, Hallervorden Spatz disease, etc. 3 . We describe a case of McLeod syndrome/ phenotype with MR features suggestive of Huntington's disease i.e. signal changes and atrophy of the caudate nucleus and putamen (i.e. neostriatum).
Case Report
A 40-year-old Indian man presented with a six-year history of abnormal generalized gradually progressive involuntary movements, mainly chorea. Initially, the movements occurred during walking and standing, but of late they were seen even at rest, interfering with daily activities. Involuntary movements was noted. There was minimal muscle atrophy in the calf muscles on both sides. However, tone and power were normal. Deep tendon reflexes were abnormal. Biceps, triceps, supinator and calf reflexes were depressed. Ankle reflexes were absent bilaterally. Plantars were bilaterally flexor. No sensory deficit could be elicited. Higher functions were normal. Other systems findings were within normal limits. No KF ring was found on slit lamp examination.
On investigations, haemoglobin was 11.5 gm%. Renal and hepatic function tests were within normal limits. Serum ceruloplasmin levels were normal. MRI brain study performed on a 1.5 T MR scanner revealed atrophic changes involving the caudate and lentiform nuclei causing the dilation of both frontal horns of the lateral ventricles. The normally convex inner aspects of the caudate nuclei had become flat to concave. On FLAIR images, hypointensity was noted in the globus pallidus and putamen suggestive of prematurely increased iron deposition in basal ganglionic regions. The cer-were also seen involving the orofacial region, tongue, lips and facial muscles (e.g. grimacing). Swallowing difficulties had recently started due to abnormal tongue movements and repeated biting of the tongue. Tics were noted. The patient had become impatient. He had had a single generalized tonic clonic convulsion a year ago, which was treated with phenobarbitone. The patient was non-diabetic, non-hypertensive, a non-smoker and non-alcoholic. There were no features suggestive of abnormal higher functions, psychiatric disorder, hepatic or renal dysfunction, thyroid or parathyroid dysfunction, rash, arthralgias, exposure to toxins or any sensory complaints. He was born of healthy parents of a non-consanguineous marriage. The family history was negative up to the preceding two generations. He has one normal healthy son aged 13 years and a 15-yearold daughter.
On examination, generalized choreiform movements and orofacial dyskinesias were observed. An extrapyramidal type of dysarthria 
Discussion
Neuroacanthocytosis is an umbrella term used to describe a group of disorders. The important disorders and their main distinguishing features are listed in Table 1 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Choreaacanthocytosis is linked to a 6-cM region of chromosome 9q21. It is common in Japan with onset usually in the third to fifth decades [9] [10] [11] . Orofaciolingual dyskinesia, chorea and dementia are the most predominant features. Many features are also shared by McLeod syndrome, a distinct form of neuroacanthocytosis with more prominent myopathy and peripheral neuropathy.
Dilated cardiomyopathy, peripheral myopathy (leading to severe rhabdomyolysis and wasting of the lower limb muscles), and autonomic disturbances are also commonly described with this syndrome/phenotype 10, 12, 13 . The movement disorder commonly develops in the fifth decade and is progressive, affecting the limbs, trunk and face. ebral peduncles showed minimal atrophy with minimal apparent reduction in the size of the pars compacta. Minimal prominence of ventricles, sulci and cisterns was also noted for his age, suggestive of minimal cerebral atrophy. The possibilities of Huntington's disease and neuroacanthocytosis were raised in view of the typical neostriatal atrophy. Subsequently, a further work-up was done. Peripheral blood smear examination done twice revealed increased acanthocyte counts of 12 and 16% respectively. Serum creatine phosphokinase (CPK) level was 1422 IU/L (increased). Serum lipid profile was within normal limits. Immunohaematology and erythrocyte membrane protein western blotting analysis confirmed the McLeod blood group phenotype by demonstrating negative Kell antigen. Electromyography and nerve conduction studies were suggestive of motor axonal degeneration in both lower limbs. Abdominal sonography revealed mild splenomegaly. The patient is being treated symptomatically. involvement may be seen during the process of degeneration only in McLeod syndrome and may be helpful in distinguishing this disease from chorea-acanthocytosis 16 . MR may show signal changes and atrophy in the neostriatum (caudate nucleus and putamen), non-specific minimal white matter changes and minimal cerebral and cerebellar atrophy 11 .
Positron emission tomography with 18Fdeoxyglucose (FDG) shows a reduction of the striatal FDG uptake 15 . Computed tomography (CT) scans of lower leg muscles reveal a selective pattern of fat infiltration in the posterior compartment with spared gracilis, semitendinosus, and the lateral head of the gastrocnemius in both McLeod syndrome and choreaacanthocytosis. However, asymmetrical muscle Table 1 ). These are also seen in Friedrich ataxia, ataxia with vitamin E deficiency, subacute combined degeneration (vitamin B12 deficiency), posterior column ataxia with retinitis pigmentosa, etc. 19 . Chorea, tics, personality changes and neostriatal atrophy on MRI are also known in Huntington's disease. However, attention to other features viz., absence of ocular motility disturbances, prominent orofacial dyskinesia, exclusively male patients, amyotrophy, areflexia, EMG evidence of axonopathy, raised serum CPK levels and the typical erythrocytic acanthocytosis can help to establish the correct diagnosis. Huntington's disease is inherited in an autosomal dominant pattern and its marker is linked to the short arm of chromosome 4. In view of the implications for genetic counselling, careful clinical and laboratory evaluation is always warranted to exclude neuroacanthocytosis in all suspected cases of Huntington's disease 18, 20 .
In conclusion, whenever marked atrophy of the neostriatum is observed on imaging, it is worthwhile considering the possibility of neuroacanthocytosis as well and do acanthocyte counts in all patients with suspected Huntington's disease.
On imaging, neostriatal atrophy involving the caudate and putamen leads to dilatation of the frontal horns of the lateral ventricles. Bicaudate diameter, bicaudate index and frontal horn/bicaudate ratio are altered 17 . Increased diffuse cerebral atrophy and secondary iron deposition in the basal ganglia (causing signal loss in these regions) may be noted. Some of them account for dementia and other abnormalities of the higher functions noted later in the disease.
Abnormal accentuated iron deposition in the basal ganglia may also be seen secondarily in various pathologies of the basal ganglia viz. demyelination, dysmyelination, ischaemia, infarction, chronic disorders, haemochromatosis, etc. 18 .
Somewhat symmetrical minimal hyperintensity may be seen on T2-weighted images in the neostriatum and is also reported in Wilson's disease, mitochondrial disorders, striatal necrosis, hepatic disorders, progressive supranuclear palsy, Huntington's disease, CJ disease, viral encephalitis, leucodystrophies, multisystem atrophy, hypoglycaemia, hypertension, haemolytic uremic syndromes, methanol intoxication, purpura, etc. 11, 18 . Dorsal spinal cord hyperintensities may be seen with abetalipoproteinaemia (one neuroacanthocytosis).
